The molecular biomarkers that have been used to identify and isolate cell populations with CSC properties, such as CD44+/CD24- and aldehyde dehydrogenase (ALDH) (Toledo-Guzmán et al., 2019), were examined in the CCT-ESCC cells as well as the parental cells. The gene discussed is CD44; the disease is esophageal squamous cell carcinoma.